Literature DB >> 12949736

Protective strategies against ischemic injury of the liver.

Nazia Selzner1, Hannes Rudiger, Rolf Graf, Pierre-Alain Clavien.   

Abstract

This article summarizes strategies to protect the liver from injuries caused by ischemia and reperfusion. Three different sections (i.e., surgical and pharmacologic strategies and gene therapy) present approaches to enhance the survival and viability of the liver in various surgical procedures including liver transplantation. The first section reviews approaches using surgical interventions such as ischemic preconditioning and intermittent clamping. Their protective effects are discussed with respect to the mechanism of injury. In the second section, pharmacologic agents targeting microcirculation, oxidative stress, proteases, and inflammation are described. Mechanisms of injury and their suppression by a wide variety of drugs are discussed. The third section focuses on gene therapy. Potential target genes have been identified (e.g., superoxide dismutase or heme oxygenase). Animal experiments in which the liver injury is reduced successfully may pave the way to novel strategies applied to different liver diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949736     DOI: 10.1016/s0016-5085(03)01048-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  134 in total

1.  Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway.

Authors:  Li-Jie Liu; Jian-Jun Yu; Xiao-Lin Xu
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.

Authors:  Sergio Duarte; Takashi Hamada; Naohisa Kuriyama; Ronald W Busuttil; Ana J Coito
Journal:  Hepatology       Date:  2012-07-11       Impact factor: 17.425

3.  Caspase inhibition in liver transplantation: from basic research to clinical studies.

Authors:  Raffaele Cursio
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

4.  Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.

Authors:  Mathilde Steenks; Mark C P M van Baal; Vincent B Nieuwenhuijs; Menno T de Bruijn; Marc Schiesser; Mike H Teo; Tom Callahan; Rob T A Padbury; Greg J Barritt
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

5.  7,8-dihydroxycoumarin has a dual mechanism of action in hepatic ischemia reperfusion injury.

Authors:  Hai-Yang Zhu; Hong-Wei Gao; Shu-Feng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  The protective effect of diosmin on hepatic ischemia reperfusion injury: an experimental study.

Authors:  Yusuf Tanrikulu; Mefaret Sahin; Kemal Kismet; Sibel Serin Kilicoglu; Erdinc Devrim; Ceren Sen Tanrikulu; Esra Erdemli; Serap Erel; Kenan Bayraktar; Mehmet Ali Akkus
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

Review 7.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

8.  BH3-only proteins contribute to steatotic liver ischemia-reperfusion injury.

Authors:  Bernard J DuBray; Kendra D Conzen; Gundumi A Upadhya; Kristen L Gunter; Jianluo Jia; Brett L Knolhoff; Thallachallour Mohanakumar; William C Chapman; Christopher D Anderson
Journal:  J Surg Res       Date:  2014-10-22       Impact factor: 2.192

Review 9.  Ischaemia-reperfusion injury in liver transplantation--from bench to bedside.

Authors:  Yuan Zhai; Henrik Petrowsky; Johnny C Hong; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

10.  Arginase blockade protects against hepatic damage in warm ischemia-reperfusion.

Authors:  Geetha Jeyabalan; John R Klune; Atsunori Nakao; Nicole Martik; Guoyao Wu; Allan Tsung; David A Geller
Journal:  Nitric Oxide       Date:  2008-04-14       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.